Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04968197 · ClinicalTrials.gov registry record · NA
Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
A NA study of Balance Disorder, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT04968197 is a NA study of Balance Disorder that has completed, run by Mayo Clinic. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04968197, a NA study of Balance Disorder, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a vestibular interventional approach using stochastic vestibular stimulation (SVS) through a small, lightweight device, and a comfortable electrode set on the back of the head that stimulates the vestibular system and produces immediate improvements in balance, gait, and overall vestibular function for patients will balance disorder.
Conditions Studied
Interventions
- DEVICE Vestibular Intervention via Portable Electrical Stimulator (VIPES) system
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04968197
The ClinicalTrials.gov registry entry for NCT04968197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Balance Disorder appearing as the primary indexed condition, and to 1 intervention - of which Vestibular Intervention via Portable Electrical Stimulator (VIPES) system is the first listed.
NCT04968197 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT04968197 about?
NCT04968197 is a clinical study titled "Vestibular Intervention Via Portable Electrical Stimulator (VIPES)". The purpose of this study is to develop a vestibular interventional approach using stochastic vestibular stimulation (SVS) through a small, lightweight device, and a comfortable electrode set on the back of the head that stimulates the vestibular system and produces immediate improvements in balance...
What is the current status of trial NCT04968197?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-09-01. Estimated completion is 2023-12-31.
What conditions does trial NCT04968197 study?
This clinical trial studies the following conditions: Balance Disorder.
What interventions are being tested in trial NCT04968197?
The interventions under investigation include: Vestibular Intervention via Portable Electrical Stimulator (VIPES) system (DEVICE).
Who is sponsoring clinical trial NCT04968197?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04968197 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.